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Objective. To determine risk factors for the development of hypertension among African-Americans living with type 1 diabetes.
Methods. African-Americans with type 1 diabetes (n = 483) participated in a 6-year followup. At both baseline and followup
blood pressure was measured twice in both sitting and standing positions using a standard protocol. Patients had a structured
clinical interview, ocular examination, retinal photographs, and blood and urine assays and completed the Hostility and Direction
of Hostility Questionnaire (HDHQ) and the Beck Depression Inventory (BDI). Results. Of the 280 diabetic patients with no
hypertension at baseline, 82 (29.3%) subsequently developed hypertension over the 6-year followup. Baseline older age, longer
durationofdiabetes,familyhistoryofhypertension,greatermeanarterialbloodpressure,overtproteinuria,increasingretinopathy
severity, peripheral neuropathy, smoking, and higher hostility scores were signiﬁcantly associated with the development of
hypertension. Multivariate analyses showed that higher hostility scores and overt proteinuria were signiﬁcantly and independently
associated with the development of hypertension in this population. Conclusions. The development of hypertension in African-
Americans living with type 1 diabetes appears to be multifactorial and includes both medical (overt proteinuria) as well as
psychological (high hostility) risk factors.
1.Introduction
Persons living with diabetes have a prevalence of systemic
hypertension twice as high as persons without diabetes
[1–5]. Hypertension is an important problem in persons
living with diabetes because it is strongly associated with
the development of the major complications of diabetes—
retinopathy, nephropathy, and cardiovascular disease [6–10].
As such, it is a major cause of morbidity and mortality
among persons living with diabetes [11, 12]. Hypertension
in persons living with diabetes appears to be more common
in African-Americans than in whites [5]. For instance,
data from the 1976–1980 National Health and Nutrition
Examination Survey for mostly type 2 diabetic persons
indicate that both systolic and diastolic blood pressures are
higher in African Americans compared with whites at ages
<54 years [5].
In persons living with diabetes, reducing morbidity and
mortalityfromhypertensionispredicatedonidentifying risk
factors associated with the development of hypertension, so
that treatment strategies may be implemented. In whites
living with type 1 diabetes, medical risk factors reported in
association with the development of hypertension include
olderage,longerdurationofdiabetes,malegender,smoking,
poor glycemic control, and proteinuria [13]. Psychological
factors have also been implicated in both the onset and
progression of hypertension in the general population [14–
17]. For example, in a meta-analysis of the relationship
of personality to blood pressure, one of the strongest
predictors of developing hypertension was found to be2 International Journal of Hypertension
ah i g hl e v e lo fa n g e r[ 15]. Furthermore, there is large
literature suggesting that hostility and negative aﬀective
states, including depression, may be a risk factor for not
only cardiovascular disease but also for hypertension [18–
30]. One reason for the association of psychological factors
with hypertension may be the exposure to chronic and
environmental stressors, particularly for African Americans
[17, 27, 31]. There is, however, no longitudinal study
examining medical and psychological risk factors for the
development of hypertension in a large group of African-
Americans living with type 1 diabetes.
We had previously examined and subsequently carried
out a 6-year followup of a large group of African-Americans
living with type 1 diabetes, the New Jersey 725 [8, 32, 33].
This 6-year followup provided an opportunity to ﬁll the
gap in knowledge about risk factors for the development of
hypertension in the 280 African-American men and women
with type 1 diabetes free of hypertension at baseline. The
purposeofthepresentstudywastoexamineputativemedical
and psychological risk factors in relation to the development
of hypertension in our African-American diabetic cohort.
2. Methods
2.1. Study Population. Description of the original cohort
has been previously reported [32]. Brieﬂy, participants were
identiﬁed from among 68,455 African-American patients
dischargedwithaprimaryorsecondarydiagnosis ofdiabetes
mellitus from 31 hospitals located in the seven counties lying
within a 20-mile radius of the New Jersey Medical School,
Newark. Approval by Institutional Review Boards at the
University of Medicine and Dentistry of New Jersey, New
Jersey Medical School, Newark, NJ, USA and at the various
hospitalswasﬁrstobtained.Subsequently,themedicalrecord
department at each hospital was given a list of potentially
eligible patients and randomly retrieved patients’ chart
for review by the Principal Investigator (MSR), the study
coordinator, andthetworesearchassistants. Fromthe review
of 13,615 patient charts, 875 patients with an acute onset
of diabetes before 30 years of age and on insulin therapy
were found to be eligible. Patients of all ages were included
in the study. Excluded were patients with type 2 diabetes,
those diagnosed after age 30 whether on insulin or not,
and patients with maturity-onset diabetes of youth [34, 35].
Of the 875 eligible patients, 725 (82.9%) were enrolled, 39
(4.4%) could not be traced, and 111 (12.7%) declined to
participate [32].
Of the 725 patients, 508 (70.1%) participated in the 6-
year follow-up examination, 44 (6.1%) could not be located,
34 (4.7%) refused examination, and 139 (19.2%) had died
in the 6-year interval [8]. Excluding patients who had died
sincebaseline, 508of the586(87%) livepatients hada 6-year
follow-up. There was no contact with participants or data
collection between the baseline and the 6-year examinations.
Atfollowup,25ofthe508(4.9%)participantswerenolonger
receiving insulin and had not received a pancreas transplant.
Since these 25 patients may not be truly insulin dependent,
they have been excluded, leaving 483 (95.1%) of the 508
patients available for analysis. Comparison between patients
on and oﬀ insulin at followup has been previously reported
[8]. The mean (±S D )t i m eo ff o l l o w - u pw a s6 . 1± 0.5 years
andmedianfollowup6.0years.Baselinecharacteristicsofthe
483 patients have been previously reported [8].
2.2. Procedures. Patients were examined in the Eye Clinic
at University Hospital in Newark, NJ USA. On arrival,
informed written consent was obtained. Similar procedures
were obtained at both baseline and 6-year follow-up visits.
Blood pressure was measured twice in both the sitting and
standing positions using a random zero sphygmomanometer
according to the Hypertension Detection and Follow-up
Program protocol [36, 37]. The technician was trained
according to a standardized protocol and was required to
meet speciﬁed performance levels prior to certiﬁcation [36].
Patients were sitting at rest for 10 minutes before any
blood pressure measurement was made, and the two blood
pressure measurements in either position were made at least
5 minutes apart. The averages of the two measurements in
each position were used. Patients also underwent a complete
eye examination and seven standard stereoscopic Diabetic
Retinopathy Study retinal photographs [38]. Also obtained
were height and weight.
A structured clinical interview included detailed medical
and ophthalmologic histories as well as sociodemographic
factors and life-style variables (i.e., self-reported measures
of smoking, alcohol consumption, and physical activity).
Patients were asked whether their mother or father had
hypertension for which they were treated. At baseline,
patients ≥18 years of age completed the Beck Depression
Inventory (BDI) [39]. The BDI is a 21-item self-report
depression inventory which measures depressive symptoms
[39]. For each item, there is a 1 to 4 score. The total score is
obtainedbyadding upthescoresoneachofthe21questions.
At the second visit, patients ≥18 years of age completed
the 51-item Hostility and Direction Hostility Questionnaire
(HDHQ) [40]. Each item is answered as either “true” or
“false”, and a scoring template is used to generate subscales
scoreswhicharesummedtoobtainatotalhostilityscore.The
HDHQ has been shown to have high validity and reliability
[40].
Color fundus photographs obtained at both baseline
and followup were graded for retinopathy severity in a
masked fashion by the Wisconsin Fundus Photograph
Reading Center in Madison, WI USA. The modiﬁed Early
Treatment of Diabetic Retinopathy Study (ETDRS) Airlie
House classiﬁcation of retinopathy was used based on the
severity level in the worse eye [41, 42]. Level 10 indicates
no retinopathy, 20–35 minimal nonproliferative retinopathy,
43–53 moderate nonproliferative retinopathy and levels ≥61
severe proliferative retinopathy [42].
Venous blood was drawn for total glycosylated hemog-
lobin, using high-pressure liquid chromatography, and high-
and low-density lipoprotein cholesterol (HDL-C and LDL-
C) and total cholesterol using an enzymatic assay and
separation spectrophotometry (Genzyme Diagnostics, Cam-
bridge, MA USA). The normal range for total glycosylated
hemoglobin is 4.2–7.0% and the intra-assay coeﬃcient of
variation 0.38–1.47%. A 4-hour timed urine collection wasInternational Journal of Hypertension 3
obtained for the measurement of albumin excretion rate
(AER)andcreatinuriausingspectrophotometry(SmithKline
Beecham Clinical Laboratory, Philadephia, PA USA).
At both visits, patients’ charts of previous hospital
admissions and/or medical notes from private physicians
were obtained and reviewed by the PI (MSR).
2.3. Deﬁnitions. Systemic hypertension was considered
present if either the systolic pressure was ≥140mmHg
and/or the diastolic ≥90mmHg, and/or the patient was
taking antihypertensive medication [43]. When reviewing
medical notes, patients’ hypertension status and prescription
of antihypertensive medications were conﬁrmed. Antihy-
pertensive medication prescribed by the patient’s physician
to only protect kidney function, as stated in the patients’
medical chart, was not considered as antihypertensive medi-
cation. When the blood pressure measurements obtained in
either the sitting or standing position diﬀered in the char-
acterization of the patient’s hypertensive status as deﬁned
above, those measurements were discarded and the blood
pressure measurements were repeated. The latter results
were used to deﬁne the patient’s hypertensive status. The
6-year incidence of hypertension was calculated from all
patients (n = 280) who did not have hypertension at the
baseline examination. Patient’s age was the age at the time
of baseline examination. Age at diagnosis was age at which
diabetes was ﬁrst recorded in the hospital record. Duration
of diabetes was time between age at diagnosis and age
at baseline. Microproteinuria was present if baseline AER
was 20–200μg/min, and overt proteinuria if baseline AER
was >200μg/min. A patient was considered depressed if at
baseline the BDI score was ≥13. BDI cut-oﬀ scores of 12
to 14 have been found to have high predictive value as a
screening instrument for depressive disorders in both the
general population and in diabetic patients [44, 45].
Socioeconomic factors recorded included patient’s level
of education (for those ≥25 years of age), marital status,
employment status, personal income (for those ≥18 years
of age), and family income. Patient’s socioeconomic status
wasclassiﬁedfromtheGoldthorpeandHopeclassiﬁcationof
occupations as middle-high (level 1–22) and lower (level 23–
36) class using the occupation of the head of the household
[46].
Alcoholabusewasconsideredpresentifthepatienteither
currently reported drinking four or more alcohol drinks
every day or had a past history of drinking four or more
alcohol drinks a day every day for at least 1 year, as also
documented from the review of the charts of all past hospital
admissions. Smoking status was quantiﬁed as packyears
calculated using the average number of cigarettes (or cigars)
perdaymultipliedbythenumberofyearsthepatientsmoked
until the baseline examination.
2.4. Statistical Tests. Data management and statistical analy-
ses were performed using window-based statistical software
(SPSS, Chicago, IL USA, version 17). Patients who did
develop hypertension over the 6-year period (or who began
usingantihypertensivemedicationduringthattime,whether
or not that treatment was eﬀective), and those who did not
were compared with regard to the various known and sus-
pected risk factors. Mean levels of continuous variables were
compared between groups with an independent samples t-
test, and rates were compared with the χ2 test. Odds ratios
(ORs) and 95% conﬁdence intervals (CIs) were also used to
quantify the association between incident hypertension and
relevant levels of each risk factor. The statistical signiﬁcance
of the associations was based on the Wald test. Rates are
presented for each level of the risk factor, and the OR is
computed with reference to the level thought to represent
the lowest risk. Multivariate logistic regression analyses
were used to identify independent risk factors for incident
hypertension. Two risk factors were categorized for analysis
because their distribution was skewed (smoking and BDI).
Continuous values were used otherwise.
Given the number of incident cases, we selected in the
multivariate regression analysis ﬁve clinical variables (age,
body mass index, smoking history, proteinuria, and family
history of hypertension) on the basis of their importance
in the literature in addition to the psychological variables
(HDHQ and depression) [47]. The ﬁrst rationale for includ-
ing these predictors concerns the number of predictors
that a regression can support [48]. Babyak suggests that
regression modeling proceed with 10–15 incident cases per
predictor. Limiting the number of predictors helps to avoid
the inﬂuence of sampling variation that may be present,
improving stability of the results and the likelihood that
results will be replicable. The hostility variable was chosen
because it represents a unique innovation of this study,
and evaluating its independence from known risk factors
(particularlydepression)wasamajorgoalofthemultivariate
analysis. The remaining variables were selected so as to
maximize consistent reports in the literature; represent a
range of causal mechanisms; modiﬁable over immutable risk
factors; and proximal (with regard to hypertension) over
more distal risks. All tests are 2-sided (where appropriate)
and all use a 0.05 signiﬁcance level.
3. Results
At baseline, the mean age of the 483 type 1 diabetic African-
American patients (288 women and 195 men) was 27.5
± 10.8 years and mean duration of diabetes 10.4 ± 8.6
years. At baseline, 203 (42.0%) of these patients already had
hypertension and were excluded from further analysis. Over
the6-yearfollowup,82ofthe280insulin-dependentpatients
[(29.3%) (95% CI, 24.0–34.9%)] without hypertension at
baseline subsequently developed hypertension. At the 6-
year followup, 60 patients were on one antihypertensive
medication (26 patients on angiotensin-converting enzyme
inhibitors (ACE), 6 on calcium channel blockers, 6 on beta-
b l o c k e r s ,a n d2o nd i u r e t i c s ) ,a n d2 0w e r eo nac o m b i n a t i o n
of antihypertensive medications. Baseline characteristics of
patients with and without hypertension at followup are
presented in Table 1.
3.1. Baseline Risk Factors for Hypertension
3.1.1. Bivariate Analyses. The incidence of hypertension
increased signiﬁcantly with increasing age at baseline from4 International Journal of Hypertension
Table 1: Baseline characteristics of patients with and without hypertension∗ at the six-year followup.
Hypertension∗
Present Absent
N† = 82 N† = 198 P‡
Mean ± SD
Age (years) 27.0 ± 9.4 24.0 ± 10.0 0.02
Duration of diabetes (years) 10.3 ± 7.6 8.1 ± 7.9 0.03
Body mass index (kg/m2) 26.6 ± 8.3 25.0 ± 6.5 0.08
Glycosylated hemoglobin (%) 14.6 ± 4.6 13.6 ± 4.3 0.08
Total cholesterol (mg/dL) 213.4 ± 58.5 189.6 ± 40.9 <0.001
Systolic blood pressure (mm Hg) 116.5 ± 11.3 114.1 ± 10.6 0.09
Diastolic blood pressure (mm Hg) 78.1 ± 8.5 75.6 ± 8.6 0.04
Mean arterial blood pressure (mmHg) 86.5 ± 8.5 82.1 ± 9.2 <0.001
Beck Depression Inventory score 11.8 ± 9.0 9.5 ± 9.1 0.08
HDHQ score§ 20.8 ± 9.1 17.1 ± 7.6 0.001
N † (%) N † (%) P||
Gender 0.89
male 31 (38.3) 74 (37.4)
Proteinuria¶ 0.001
none 48 (60.8) 152 (78.4)
micro- 19 (24.1) 33 (17.0)
overt 12 (15.2) 9 (4.6)
Retinopathy severity# <0.001
none 32 (39.5) 111 (56.1)
minimal 25 (30.9) 74 (37.4)
moderate 13 (16.0) 9 (4.5)
severe 11 (13.6) 4 (2.0)
Peripheral neuropathy 0.001
yes 45 (55.6) 67 (33.8)
Stroke 0.77
yes 3 (3.7) 6 (3.0)
Heart disease 0.34
yes 10 (12.3) 17 (8.6)
Total Cholesterol/HDL-C∗∗ ≥4.5 0.15
yes 49 (73.1) 146 (81.6)
Smoking 0.03
ever 43 (53.1) 77 (38.9)
Family history of hypertension 0.05
yes 47 (59.5) 88 (46.6)
∗Systolic ≥140 and/or diastolic ≥90mm Hg or use of antihypertensive medication; †N may vary due to missing data; ‡t-test; §Hostility and Direction of
Hostility Questionnaire [40]; ||chi-square test; ¶a l b u m i ne x c r e t i o nr a t e :n o n e<20μg/min, micro- 20–200μg/min, overt >200μg/min; #Early Treatment of
Diabetic Retinopathy Study severity level [42]; ∗∗high-density lipoprotein cholesterol.
13.6%inthose<10yearsofageto40.9%inthose>30yearsof
age (test for trend, P<0.01). The incidence of hypertension
also increased with longer baseline duration of diabetes from
19.8% in patients with ≤5 years of diabetes to 40.0% in those
with>20 years of diabetes duration (test for trend, P<0.01).
There was no signiﬁcant association with gender.
The 6-year incidence of hypertension was signiﬁcantly
associatedwithbaselinelongerdurationofdiabetes(P=0.02),
more years of smoking (P = 0.008), a family history of
hypertension(P = 0.04),highermeanarterialbloodpressure
(P = 0.001), overt proteinuria (P = 0.001), moderate to
severe diabetic retinopathy (P<0.001), peripheral neuropa-
thy (P = 0.001), and a higher HDHQ score (P = 0.001)
(Table 2).
There was no signiﬁcant association between developing
hypertension and baseline body mass index (P = 0.46),International Journal of Hypertension 5
Table 2: Six-year incidence of hypertension∗ by baseline characteristics: bivariate analysis.
Baseline characteristics No. at risk† Crude (%) OR (95% CI)‡ P||
Glycosylated hemoglobin (%)¶ 0.11
<10.4 64 31.3 1.0
10.41–13.45 74 23.0 0.66 (0.31–1.40)
13.46–16.2 68 23.5 0.68 (0.31–1.46)
>16.2 74 39.2 1.42 (0.70-2.87)
Retinopathy severity <0.001
none 143 22.4 1.0
minimal 100 26.0 1.22 (0.67–2.21)
moderate 22 59.1 5.01 (1.96–12.78)
severe 15 73.3 9.54 (2.84–31.99)
Proteinuria# 0.001
none 200 24.0 1.0
micro- 52 36.5 1.82 (0.95–3.50)
overt 22 59.1 4.57 (1.84–11.36)
Peripheral neuropathy 0.001
no 167 21.6 1.0
yes 113 40.7 2.50 (1.48–4.23)
Total cholesterol/HDL-C∗∗ 0.16
<4.5 196 25.5 1.0
≥4.5 51 35.3 1.59 (0.83–3.08)
HDHQ score¶†† 0.001
0–12 71 18.3 1.0
13–16 51 27.5 1.69 (0.71–3.99)
17–23 62 30.6 1.97 (0.88–4.42)
≥24 63 44.4 3.57 (1.64–7.79)
BDI score ≥13‡‡ 0.20
no 159 27.7 1.0
yes 63 36.5 1.50 (0.81–2.79)
Smoking (packyears)¶ 0.008
0 160 24.4 1.0
<5 44 29.5 1.34 (0.64–2.81)
5–14 40 32.5 1.53 (0.72–3.26)
≥15 36 47.2 2.85 (1.35–6.03)
Body mass index (Kg/m2) .46
<25 153 27.5 1
>25 127 31.5 1.22 (0.73–2.04)
Duration of diabetes (years)¶ .02
<5 111 20.7 1
5–9 69 36.2 2.17 (1.10–4.26)
10–17 57 28.1 1.49 (0.71–3.12)
≥18 43 41.9 2.76 (1.29–5.89)
Family history of hypertension .04
no 133 24.1 1
yes 136 35.3 1.72 (1.01–2.93)
Mean arterial blood pressure (mmHg)|||| .001
<82.2 113 23.9 1
82.3–90.5 105 22.9 0.94 (0.50–1.77)
>90.5 62 50.0 3.19 (1.65–6.16)6 International Journal of Hypertension
Table 2: Continued.
Baseline characteristics No. at risk† Crude (%) OR (95% CI)‡ P||
Education 0.32
≤high school 75 37.3 1
≥college 71 29.6 0.71 (0.35–1.41)
Socioeconomic status 0.30
middle-high 133 26.3 1
lower 147 32.0 1.32 (0.78–2.21)
Alcohol abuse 0.09
no 240 24.6 1
yes 19 42.1 2.23 (0.86–5.81)
∗Systolic ≥140 or diastolic ≥90mm Hg orantihypertensivemedication; †numberat risk may varydue to missingdata; ‡oddsratio(95% conﬁdence interval);
||test for trend, using Cochran Armitage trend test; ¶quartiles; #albumin excretion rate: none <20μg/min; micro- 20–200μg/min; overt >200μg/min; ∗∗high-
density lipoprotein cholesterol; ††HDHQ: Hostility and Direction of Hostility Questionnaire score [40]; ‡‡Beck Depression Inventory score ≥13 at visit 1
[39]; ||tertiles.
Table 3: Six-year incidence of hypertension∗ by baseline character-
istics: multivariate analysis.
Characteristic OR (95% CI)† P‡
Age (per year) 0.99 (0.95–1.04) 0.88
Body mass index (per Kg/m2) 1.02 (0.98–1.07) 0.37
Smoking (packyears)§ 0.67
01 . 0
<5 0.98 (0.43–2.24)
5–14 1.20 (0.50–2.89)
≥15 2.04 (0.74–5.62)
Family history of hypertension|| 1.63 (0.87–3.05) 0.13
Proteinuria¶ 0.16
none 1.0
micro- 1.39 (0.63–3.09)
overt 3.00 (1.03–8.73)
HDHQ score 1.06 (1.02–1.10) 0.001
∗Systolic ≥140 or diastolic ≥90mm Hg or antihypertensive medication;
†oddsratio(95%conﬁdenceinterval); ‡P values; §quartiles; ||presentversus
absent; ¶microalbuminuria versus none and overt proteinuria versus none.
insulin dose (P = 0.14), level of education (P = 0.30),
socioeconomic status (P = 0.32), alcohol abuse (P = 0.09),
blood total cholesterol levels (P = 0.23), total cholesterol/
HDL-C (P = 0.16), glycosylated hemoglobin values (P =
0.11), or being depressed (P = 0.20).
3.1.2. Multivariate Analyses. Multivariate logistic regression
was used to evaluate the relative contribution of the baseline
risk factors to the development of hypertension. Higher
HDHQ scores and overt proteinuria were signiﬁcantly and
independently associated with the 6-year incidence of hyper-
tension in this population (Table 3). This result was obtained
whether or not depression was included in the model,
suggesting that hostility makes a contribution to incident
hypertension that is independent of depression (Table 4).
The set of predictors produced a signiﬁcant improvement
in ﬁt (χ2 (14) = 33.0, P = 0.003) over an intercept-only
Table 4: Six-year incidence of hypertension∗ by baseline character-
istics: multivariate analysis.
Characteristic OR (95% CI)† P‡
Age (per year) 1.00 (0.95–1.05) 0.99
Body mass index (per Kg/m2) 1.04 (0.99–1.09) 0.09
Smoking (packyears)§ 0.51
01 . 0
<5 0.71 (0.27–1.89)
5–14 0.89 (0.34–3.32)
≥15 1.93 (0.66–5.64)
Family history of hypertension|| 1.54 (0.78–3.04) 0.21
Proteinuria¶ 0.05
none 1.0
micro- 1.74 (0.73–4.19)
overt 3.75 (1.26–11.16)
HDHQ score 1.08 (1.03–1.13) 0.002
BDI score ≥13∗∗ 0.64 (0.29–1.43) 0.28
∗Systolic ≥140 or diastolic ≥90mm Hg or antihypertensive medication;
†odds ratio (95% conﬁdence interval); ‡P values; §quartiles; ||present
versus absent; ¶microalbuminuria versus none and overt proteinuria versus
none; #Hostility and Direction of Hostility Questionnaire score [40];
∗∗Beck Depression Inventory score ≥13 at visit 1: depressed versus not
depressed [39].
model, and the Hosmer-Lemeshow statistic was consistent
with good overall ﬁt (χ2 (8) = 9.7, P = 0.29). The model also
showed good discrimination, as indexed by ROC analysis
(AUC = 0.65, 95% CI = 0.56, 0.73); however, while there
wasexcellentspeciﬁcity(92.3%),sensitivitywaslow(36.7%).
Interestingly, while age, family history of hypertension, and
years of smoking showed signiﬁcant bivariate associations
with incident hypertension, these factors did not make an
independent contribution.
The analyses show a signiﬁcant and independent asso-
ciation between baseline overt proteinuria and incident
hypertension whether or not depression was included in
the model (Tables 3 and 4). The association betweenInternational Journal of Hypertension 7
proteinuria and hypertension suggests a causal pathway in
which proteinuria precedes hypertension. To support this
causal inference, we conducted a logistic regression analysis,
otherwise parallel to that shown above, in which baseline
hypertension was used as predictor of incident proteinuria.
Results showed a statistically and clinically similar 6-year
incidence of overt proteinuria in patients with (14.5%)
or without (12.3%) hypertension at baseline, even after
adjusting for family history of hypertension. Thus, while
overt proteinuria is a risk factor for the 6-year incidence of
hypertension, hypertension is not a risk factor for the 6-year
incidence of overt proteinuria.
4. Discussion
Inthepresentstudy,wefoundthatahighpercentage(29.3%)
of 280 African-Americans with type 1 diabetes, who had no
hypertension at baseline, subsequently developed hyperten-
sion over a 6-year follow-up period. Baseline psychological
(high HDHQ score) and medical (overt proteinuria) risk
factors were found to be independent predictors for the
development of hypertension in this cohort.
In white persons with type 1 diabetes, the 10-year inci-
dence of hypertension was also found to be a high (25.9%)
by Klein et al., albeit a lower rate than the 6-year incidence of
29.3% in our type 1 diabetic African-Americans [13]. It has
been similarly reported that African-Americans with type 2
diabetes have a higher risk for developing hypertension than
their white type 2 counterparts [5]. The apparent higher
risk of hypertension in African-Americans compared with
whites, particularly in those with diabetes, is incompletely
understood though it is noteworthy that the etiology of
hypertension is generally thought to be multifactorial and to
include medical, lifestyle, psychological, and genetic factors
[13, 17, 31, 49].
To the best of our knowledge, risk factors associated with
the development of hypertension have not been previously
examined in a large cohort of African Americans living with
type 1 diabetes. When we examined possible medical risk
factors,wefoundthatbaselineovertproteinuria wastheonly
independent medical risk factor associated with developing
hypertension in our African-American patients. In type 1
diabetic whites baseline proteinuria was also reported to
be an independent predictor for developing hypertension
[7,13,49].Whilethetimerelationshipbetweenhypertension
and proteinuria is not always clear, our data indicate that in
thiscohortovertproteinuria precedesratherthanfollowsthe
development of hypertension since patients with and those
withouthypertensionatbaselinehaveasimilarriskofhaving
overt proteinuria at the 6-year followup (see results) [50].
It is noteworthy that a high 37% of our African American
patients with <5 years duration of diabetes at baseline had
developed proteinuria at the 6-year follow-up [51]. Not
only are African Americans living with type 1 diabetes at a
particularly high risk for diabetic nephropathy, but they also
develop this complication relatively early after diagnosis of
diabetes [51]. Thus, evaluating kidney function early after
diagnosis of diabetes, and regularly thereafter, is critically
important in African Americans living with type 1 diabetes
in order to reduce morbidity and mortality from the disease
[9, 12, 51].
Because African-Americans as a group are more likely
to experience chronic sociocultural stressor, we were par-
ticularly interested in determining the respective role of
psychological risk factors for hypertension [17, 27, 31, 52].
Our data show that a high hostility score on the HDHQ was
signiﬁcantly and independently associated with developing
hypertension, even after adjusting for the traditional medical
risk factors as well as for depression. While HDHQ and BDI
measures showed signiﬁcant levels of association (r = 0.37,
df = 394, P<0.001), that aspect of hostility which is related
to incident hypertension does not appear to be related to
depression, as depression was not associated with incident
hypertension in this population (Table 3). Our data are in
accord with a large literature suggesting that hostility may be
ariskfactorforcardiovasculardiseaseandhypertension[14–
31].Forexample,SuarezandWilliamsshowedthatbothmen
and women with high hostility scores on the Cooke Medley
Hostilityscalerespondedtoasolvableanagramtask—during
which they were harassed—with greater diastolic blood
pressure, greater forearm blood ﬂow, and prolonged systolic
blood pressure [23, 53]. They went on to demonstrate that
highhostilityindividualsalsohadsigniﬁcantlyenhancedand
prolonged plasma norepinephrine and cortisol responses
compared to low hostility subjects [54].
Also akin to the hostility ﬁndings of the present study
is a 4-year follow-up study of 537 normotensive Finnish
men [55]. In that study, each 1-point increase in anger-out
on the Spielberger Anger Expression scale was associated
with a 12% increase in the risk of developing hypertension
[55]. Similarly, Bleil et al. found in 237 men with untreated
hypertension that trait anger, anger temperament, and a
propensity to express anger outwardly (anger-out) on the
Spielberger scale were associated with heightened carotid
atherosclerosis as measured by B-scan ultrasonography [56].
African-Americans may be more likely than whites to
experience chronic sociocultural stressors and associated
suppressed anger. For instance, in African-Americans living
in high-stress areas in Detroit, suppressed anger was shown
to be associated with elevated blood pressure [57].
In the present study, baseline years of smoking were
signiﬁcantly associated with the development of hyperten-
sion on bivariate analyses as previously reported in other
studies [58, 59]. In a recent study, smoking in persons
with mental illness was signiﬁcantly associated with the
development of hypertension [57]. Smoking is a known
risk factor for cardiovascular disease, including coronary
disease and stroke [60]. In this regard, it is noteworthy
that smoking has been reported to increase arterial stiﬀness,
promote atherosclerosis and inﬂammation, and lead to
alteration in blood rheology [61]. However, smoking was
no longer signiﬁcant in the multivariate analyses because
of its signiﬁcant association with both the HDHQ score
and proteinuria (data not shown). Similarly, age, family
history of hypertension, and body mass index were not
independent risk factors for incident hypertension because
of their signiﬁcant association with overt proteinuria (data
not shown).8 International Journal of Hypertension
Strengths of the present study include that the sample
is a large cohort of African-Americans living with type 1
diabetes; patients were followed for a mean of 6 years; both
medical, lifestyle, and psychological risk factors were exam-
ined; a detailed medical history was obtained; standardized
questionnaires were used to evaluate psychological factors;
retinopathy severity was graded in a masked fashion on two
separate occasions.
Limitations of the present study include that we did
not have African-Americans without diabetes serving as a
control group. Furthermore, at the time of followup, 139
patients had died, and many patients included in the study
were young. Therefore, the incidence of hypertension may
be underestimated. Also blood pressure measurements were
made on one single rather than on two separate visits,
and there were no at-home or ambulatory measures of
blood pressure [37]. Thus, the possibility of hypertension
status misclassiﬁcation exists. However, blood pressure was
obtained by a certiﬁed technician using a standardized
protocol and the random zero sphygmomanometer, a period
of resting time was observed before and in between measure-
ments, and measurements were repeated when there was a
discrepancy in the results. Also, we used the cutoﬀ score of
≥140 and/or ≥90mm Hg for systolic and diastolic hyper-
tension, respectively, which is higher than the target blood
pressure of <130/80mm Hg recommended for hypertensive
patientswithdiabetes[37].Duetotimeconstraints,abattery
of anger and anxiety measures was not administered. HDHQ
scores measure trait rather than state hostility and thus are
unlikely to be unduly impacted by diabetic complications.
Finally, our patients were initially recruited from among
patients admitted to hospital at some time during their
life and may thus have more severe disease than persons
living with type 1 diabetes but were never admitted to
hospital. Thus, we cannot conclude that our ﬁndings can be
generalized beyond the population that was studied.
In summary, as far as we are aware, this is the ﬁrst stu-
dy reporting incidence rates of and risk factors for the
development of hypertension in a large population of
African-Americans living with type 1 diabetes. The results
show that both medical risk factors—overt proteinuria—
and psychological risk factors—high hostility score—may
play a role. Thus, the results suggest the possibility of a
multifactorial model for the development of hypertension in
type 1 diabetic African-Americans. The potential impact of
the ﬁndings in terms of clinical intervention might include
the early identiﬁcation of modiﬁable risk factors, which
may be helpful in reducing the morbidity and mortality
associated with diabetes.
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